950525-69-6

Upstream product

• 585-81-9 3-hydroxy-5-methylbenzoic acid 
• 14001-63-9 2-methylthio-4-methylpyrimidine 
• 108593-44-8 methyl 3-methoxy-5-methylbenzoate 

Downstream Products

• 1262110-36-0 [4-[2-(3-hydroxyazetidin-1-yl)-pyrimidin-4-yl]-3-(3-hydroxy-5-methylphenyl)-pyrazol-1-yl]acetonitrile 
• 1262110-35-9 [4-[2-(3-hydroxyazetidin-1-yl)-pyrimidin-4-yl]-3-(3-methoxy-5-methylphenyl)-pyrazol-1-yl]acetonitrile 
• 1262110-38-2 [4-[2-(3(S)-hydroxypyrrolidin-1-yl)-pyrimidin-4-yl]-3-(3-hydroxy-5-methylphenyl)-pyrazol-1-yl]acetonitrile 
• 1262110-37-1 [4-[2-(3(S)-hydroxypyrrolidin-1-yl)-pyrimidin-4-yl]-3-(3-methoxy-5-methylphenyl)-pyrazol-1-yl]acetonitrile 
• 1262110-34-8 [4-(2-methanesulfonylpyrimidin-4-yl)-3-(3-methoxy-5-methylphenyl)-pyrazol-1-yl]acetonitrile 
• 1262110-33-7 [3-(3-methoxy-5-methylphenyl)-4-(2-methylthio-pyrimidin-4-yl)-pyrazol-1-yl]acetonitrile 
• 950525-67-4 4-[3-(3-methoxy-5-methylphenyl)-1H-pyrazol-4-yl]-2-(methylsulfanyl)pyrimidine 

Relevant academic research and scientific papers

Design, Synthesis, and In Vitro Cytotoxic Activity of Certain 2-[3-Phenyl-4-(pyrimidin-4-yl)-1H-pyrazol1-yl]acetamide Derivatives

Abstract: With a view to finding new anticancer agents, different aryloxy groups wereattached to C2 of the pyrimidine ring in2-[3-phenyl-4-(pyrimidin-4-yl)-1H-pyrazol-1-yl]acetamide in five steps using methyl3-methoxy-5-methylbenzoate as the ke

PYRAZOLE COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST ROS KINASE

Disclosed herein are novel pyrazole compounds, pharmaceutically acceptable salts thereof, a method for preparing the same, and uses thereof as anticancer agents.